I am a healthcare professional in the UK
I am a patient or member of the public
Prescribing Information and Adverse Events Reporting
Prescribing Information and Adverse Events Reporting
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Takeda UK Ltd. at: AE.GBR-IRL@takeda.com.
ADVATE (octocog alfa)
CEPROTIN® (human protein c)
CINRYZE® ▼ (human c1-esterase inhibitor)
CUVITRU® (human normal immunoglobulin)
ELAPRASE® ▼ (idursulfase)
FEIBA® (factor VIII inhibitor bypassing activity)
FIRAZYR® (icatibant)
HYQVIA® (human normal immunoglobulin)
KIOVIG® (human normal immunoglobulin)
LIVTENCITY® ▼ (maribavir)
OBIZUR® ▼ (susoctocog alfa)
PROTHROMPLEX TOTAL® (human prothrombin complex)
REPLAGAL® (agalsidase alfa)
TAKHZYRO® (lanadelumab)
VEYVONDI® (vonicog alfa)
VPRIV® (velaglucerase alfa)
